VAISHALI PHARMA
Back to Income Statement
|
VAISHALI PHARMA Last 5 Year Revenue History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Sales | ₹70 Cr | ₹76 Cr | ₹54 Cr | ₹60 Cr | ₹75 Cr |
What is the latest Revenue of VAISHALI PHARMA ?
Year | Revenue |
---|---|
Mar2023 | ₹70 Cr |
Mar2022 | ₹76 Cr |
Mar2021 | ₹54 Cr |
Mar2020 | ₹60 Cr |
Mar2019 | ₹75 Cr |
How is Revenue of VAISHALI PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2023 | ₹70 Cr | -8.12 | |
Mar2022 | ₹76 Cr | 41.00 | |
Mar2021 | ₹54 Cr | -10.50 | |
Mar2020 | ₹60 Cr | -19.98 | |
Mar2019 | ₹75 Cr | - |
Compare Revenue of peers of VAISHALI PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VAISHALI PHARMA | ₹169.6 Cr | -2.1% | 13.9% | 9.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
VAISHALI PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VAISHALI PHARMA | -2.1% |
13.9% |
9.4% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses